What's New :
TARGET PT 2022: Batch will be started from 6th December, 2021
GS PAPER-2 (New Batch will be started from 06th December, 2021)
IAS Foundation 2023-24: New Batch will be started from 14th December, 2021

Weekly Current Affairs: April week-2 - Convalescent-plasma therapy

  • Category
    Science & Technology
  • Published
    9th Apr, 2020

The United States’ Food and Drug Administration is developing a new coronavirus drug derived from the blood plasma of people who have recovered from Covid-19. Its approach is based on the idea that antibodies developed by recovered patients might strengthen the immune system of new patients.

Context

The United States’ Food and Drug Administration is developing a new coronavirus drug derived from the blood plasma of people who have recovered from Covid-19. Its approach is based on the idea that antibodies developed by recovered patients might strengthen the immune system of new patients.

You must be logged in to get greater insights.
X
Enquire Now